Crossing blood-brain barrier: New hope for new class of Alzheimer's disease drugs

Finding a drug that can cross the blood-brain barrier is the bane of drug development for Alzheimer's disease and other neurological disorders of the brain. A new study has found and tested in an animal model of Alzheimer's disease a class of drug that is able to enter the brain, where it stabilizes degenerating neurons and improves memory and learning.

Read the whole article on Science Daily

More from Science Daily